Table 4 Adverse events after baseline but before recurrence of parasitaemia occurring in > 5% of patients, by body weight group
Adverse Events | n (%) | |||
|---|---|---|---|---|
BWG1 5-<10 kg (N = 50) | BWG2 10-<15 kg (N = 37) | BWG3 15-<25 kg (N = 16) | Ttotal 5-<25 kg (N = 103) | |
Anaemia | 32 (64.0) | 20 (54.1) | 7 (43.8) | 59 (57.3) |
Cough | 20 (40.0) | 11 (29.7) | 2 (12.5) | 33 (32.0) |
Hepatomegaly | 9 (18.0) | 12 (32.4) | 5 (31.3) | 26 (25.2) |
Respiratory tract infection | 21 (42.0) | 9 (24.3) | 1 (6.3) | 31 (30.1) |
Splenomegaly | 10 (20.0) | 9 (24.3) | 2 (12.5) | 21 (20.4) |
Diarrhoea | 11 (22.0) | 7 (18.9) | 2 (12.5) | 20 (19.4) |
Vomiting | 10 (20.0) | 3 (8.1) | 5 (31.3) | 18 (17.5) |
Rashes | 11 (22.0) | 5 (13.5) | 1 (6.3) | 17 (16.5) |
Anorexia | 9 (18.0) | 5 (13.5) | 1 (6.3) | 15 (14.6) |
Clonus | 7 (14.0) | 5 (13.5) | 1 (6.3) | 13 (12.6) |
Insomnia | 7 (14.0) | 3 (8.1) | 1 (6.3) | 11 (10.7) |
Catarrh | 4 (8.0) | 5 (13.5) | 0 (0.0) | 9 (8.7) |
Hypothermia | 5 (10.0) | 1 (2.7) | 0 (0.0) | 6 (5.8) |
Hyperreflexia | 3 (6.0) | 2 (5.4) | 1 (6.3) | 6 (5.8) |